We invite you to join a pioneering migraine treatment study led by Prof. Wöber, Head of the Headache Clinic at AKH Vienna, and supported by Brightmind.AI’s groundbreaking technology. Together, we aim to improve migraine prevention and offer hope to millions.

Why Join?

• Innovative Technology: Our brain stimulation method has been shown to reduce migraine frequency by 50% in 90% of participants according to published studies.
• Proven Results: Pilot studies by Brightmind.AI and independent research groups confirm promising outcomes.

Study Highlights:

• Start Dates: Choose to begin in January or February 2025.
• Simple Schedule: Three 30-minute stimulation sessions over 10 days.
• Convenient Location: University Clinic for Neurology, AKH Vienna.
• Eligibility: Open to those experiencing 4+ migraine days per month.
• Compensation: Participants receive fair reimbursement for their time.